DescriptionNext in the AAPM&R Expert Conversations webinar series hosted by the Health Policy, Practice, and Advocacy Committee, hear from your colleagues and policy experts about the latest regulatory developments in IRFs and what they mean for your practice. CMS has implemented big changes in the
Final Rule for inpatient rehabilitation facilities (IRFs) that took effect on October 1 and recently convened a Technical Expert Panel to discuss proposed changes to the IRF Prospective Payment System. CMS has also announced expansion of the IRF Review Choice Demonstration (RCD) to more states starting January 1. Learn the latest policy details as well as insights CMS has shared with us for how you can boost documentation to ensure compliance, decrease denied admissions, and advocate for your patients. Bring your questions. Time will be set aside for live Q&A.
Learing Objectives
As a result of attending this session, participants will be able to:
- IRF medical necessity policies: what’s changing and how to document to meet the new requirements
- IRF Review Choice Demonstration (RCD): where it stands and how to prepare for participation in expansion states
- IRF audits: current trends, common pitfalls, and how to respond, including tips for appealing denied claims
- IRF Technical Expert Panel (TEP) issues: key takeaways and how they may shape future policy
- AAPM&R advocacy: what are the Academy's priorities and how can you participate?
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live activity/enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with
any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships. Through the planning process, all relevant financial relationships have been mitigated.
Principle Faculty
Susan Hubbell, MD: Disclosed no relevant financial relationships.
Peter Thomas, JD, Powers Law: Disclosed no relevant financial relationships.
AAPM&R Medical Education Committee
Rachel A. Brakke Holman, MD, Chair: Disclosed no relevant financial relationships.
Sarah M. Eickmeyer, MD: Disclosed no relevant financial relationships.
Chelsea D. Frost, MD, MS: Disclosed no relevant financial relationships.
David J. Haustein, MD, MBA: PM Consulting, Expert Medical Consulting: Ownership or Partnership; Greene County Medical Society Executive Council, Missouri State Medical Foundation Board: Non-remunerative Positions of Influence
Sarah K. Hwang, MD: Disclosed no relevant financial relationships.
Ravi E. Kasi, MD: Disclosed no relevant financial relationships.
Caroline Pupke, DO: Disclosed no relevant financial relationships.
Monica E. Rho, MD: Disclosed no relevant financial relationships.
McCasey R. Smith, MD: Disclosed no relevant financial relationships.
Jennifer A. Soo Hoo, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Justin L. Weppner, DO: Disclosed no relevant financial relationships.
Alexandra G. Wolfe, DO: Disclosed no relevant financial relationships.
FDA Disclosures
Any faculty member for this activity who intends to discuss or demonstrate any pharmaceutical or
medical device for which FDA clearance has not been approved, will verbally disclose the FDA’s
classification at the beginning of their presentation or demonstration.